Prognostic Value of Plasma hPG(80) (Circulating Progastrin) in Metastatic Renal Cell Carcinoma

SIMPLE SUMMARY: Metastatic renal cell carcinoma (mRCC) accounts for one-third of all newly diagnosed renal cell cancers. A better understanding of the biology and molecular basis of disease progression has resulted in several drug targets being identified and led to approval of several new drugs for...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohli, Manish, Tan, Winston, Vire, Bérengère, Liaud, Pierre, Blairvacq, Mélina, Berthier, Frederic, Rouison, Daniel, Garnier, George, Payen, Léa, Cousin, Thierry, Joubert, Dominique, Prieur, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864155/
https://www.ncbi.nlm.nih.gov/pubmed/33498444
http://dx.doi.org/10.3390/cancers13030375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864155/
https://www.ncbi.nlm.nih.gov/pubmed/33498444
http://dx.doi.org/10.3390/cancers13030375

Ejemplares similares